Enterologicsis assembling a scientific advisory board of thought leaders in gastroenterology and microbiology.Members will be announced in the near future.
The scientific advisory board will help us to identify and select candidate probiotic strains for clinical development. Because probiotic bacteria have unique characteristics and potential mechanisms of action in the body, the board will also help match those qualities with particular disease conditions that are inadequately addressed by current therapies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.